You are here

Mark Senak

There has been growing concern in the U.S. over the issue ofimportation, pertaining not only to the importation of prescriptiondrugs for personal use, but drugs, or drug components manufacturedoverseas and imported into the U.S. (i.e., heparin). The FDA on Tuesdayannounced the issuance of Warning Letters to Ranbaxy, the Indiangeneric giant.